These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Isolation and identification of ten new sildenafil derivatives in an alleged herbal supplement for sexual enhancement.
    Author: Assemat G, Balayssac S, Gilard V, Martins-Froment N, Fabing I, Rodriguez F, Génisson Y, Martino R, Malet-Martino M.
    Journal: J Pharm Biomed Anal; 2020 Nov 30; 191():113482. PubMed ID: 32898728.
    Abstract:
    A sexual enhancer dietary supplement in pre-commercialization phase was analyzed. It contained the two phosphodiesterase-5 inhibitors (PDE-5i) sildenafil and methisosildenafil as major adulterants. Fourteen more sildenafil derivatives were detected and after isolation, their structures were elucidated thanks to NMR, high resolution and tandem mass spectrometry, and UV spectroscopy. Ten of them were never described. All these compounds are probably by-products of different reaction steps during the synthesis of the two PDE-5i that were not properly eliminated during the purification procedure. The total amount of sildenafil-related compounds was estimated at 68 mg per capsule, sildenafil and methisosildenafil accounting for 20 mg and 38 mg respectively.
    [Abstract] [Full Text] [Related] [New Search]